100 related articles for article (PubMed ID: 1268139)
1. Plasminogen activators in the endometrium of women using intrauterine contraceptive devices.
Kasonde JM; Bonnar J
Br J Obstet Gynaecol; 1976 Apr; 83(4):315-9. PubMed ID: 1268139
[TBL] [Abstract][Full Text] [Related]
2. Fibrinolytic activity in utero and bleeding complications with intrauterine contraceptive devices.
Bonnar J; Kasonde K; Haddon M; Hassanein MK; Allington MJ
Br J Obstet Gynaecol; 1976 Feb; 83(2):160-4. PubMed ID: 148902
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolytic activity in bleeding associated with intrauterine contraceptive devices.
Khanna A; Biswas AK; Dubey B; Khanna AK
Indian J Med Res; 1992 Jun; 96():147-9. PubMed ID: 1512035
[TBL] [Abstract][Full Text] [Related]
4. [An analysis of complications and bacteriological and histological studies following extraction of an intrauterine contraceptive device (Beospir) which was inserted several years ago].
Kracunović M; Oprić M
Jugosl Ginekol Opstet; 1980; 19(3-4):191-4. PubMed ID: 7412377
[TBL] [Abstract][Full Text] [Related]
5. Reduced plasminogen activator content of the endometrium in oral contraceptive users.
Casslén B; Astedt B
Contraception; 1983 Aug; 28(2):181-8. PubMed ID: 6685602
[TBL] [Abstract][Full Text] [Related]
6. The response of endometrial blood vessels to intrauterine contraceptive devices: an electron microscopic study.
Sheppard BL; Bonnar J
Br J Obstet Gynaecol; 1980 Feb; 87(2):143-54. PubMed ID: 7362802
[TBL] [Abstract][Full Text] [Related]
7. Endometrial lysosomal enzyme activity in ovulatory dysfunctional uterine bleeding, IUCD users and post-partum women.
Wang IY; Fraser IS; Barsamian SP; Manconi F; Street DJ; Cornillie FJ; Russell P
Mol Hum Reprod; 2000 Mar; 6(3):258-63. PubMed ID: 10694274
[TBL] [Abstract][Full Text] [Related]
8. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
[TBL] [Abstract][Full Text] [Related]
9. Increased fibrinolytic activity in the endometrium of patients using copper-iud (gravigard).
Larsson B; Liedholm P; Astedt B
Int J Fertil; 1975; 20(2):77-80. PubMed ID: 3481
[TBL] [Abstract][Full Text] [Related]
10. Haemostasis in menstrual endometrium in the presence of an intrauterine device.
Christiaens GC; Sixma JJ; Haspels AA
Br J Obstet Gynaecol; 1981 Aug; 88(8):825-37. PubMed ID: 7260004
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of the intrauterine contraceptive device: evidence for a specific biochemical deficiency in the endometrium.
Seleem S; Hills FA; Salem HT; El-Nashar EM; Chard T
Hum Reprod; 1996 Jun; 11(6):1220-2. PubMed ID: 8671427
[TBL] [Abstract][Full Text] [Related]
12. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic activity of menstrual blood in normal and menorrhagic women and in women wearing the Lippes Loop and the Cu-T (200).
Hefnawi F; Saleh A; Kandil O; El-Sheikha Z; Hassanein M; Askalani H
Int J Gynaecol Obstet; 1979; 16(5):400-7. PubMed ID: 35409
[TBL] [Abstract][Full Text] [Related]
14. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
15. No increase of the fibrinolytic activity of the human endometrium by progesterone-releasing IUD (progestasertR).
Liedholm P; Sjöberg NO; Srivastava K; Astedt B
Contraception; 1978 Jun; 17(6):531-3. PubMed ID: 668372
[TBL] [Abstract][Full Text] [Related]
16. Effect of intrauterine contraceptive devices on cytokine messenger ribonucleic acid expression in the human endometrium.
Ammälä M; Nyman T; Strengell L; Rutanen EM
Fertil Steril; 1995 Apr; 63(4):773-8. PubMed ID: 7890061
[TBL] [Abstract][Full Text] [Related]
17. Effect of copper and plastic intra-uterine devices on the fibrinolytic activity of the endometrium in the rat.
Larsson B; Liedholm P; Astedt B
Int J Fertil; 1975; 20(3):145-50. PubMed ID: 4394
[TBL] [Abstract][Full Text] [Related]
18. [Morphological changes in the endometrium of women using an intrauterine contraceptive device].
Grishchenko VI; Iakovtsova AF; Liss NL; Titarenko LE; Ofitserov VN
Akush Ginekol (Mosk); 1980 Mar; (3):41-2. PubMed ID: 7377499
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E and F concentrations in human endometrium after insertion of intrauterine contraceptive device.
Hillier K; Kasonde JM
Lancet; 1976 Jan; 1(7949):15-6. PubMed ID: 54517
[TBL] [Abstract][Full Text] [Related]
20. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF
Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
